Mesenchymal bone marrow-derived stem cells transplantation in patients with hcv related liver cirrhosis

Journal of Clinical and Translational Hepatology

Volumn 2, Issue 4, 2014, Pages 217-221

  Lukashyk, Sviatlana P ^a   Tsyrkunov, Vladimir Maksimovich ^b   Isaykina, Yanina I ^c   Romanova, Oksana N ^c   Shymanskiy, Artur T ^c   Aleynikova, Olga V ^c   Kravchuk, Rimma I ^b  

^a BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

^b GRODNO STATE MEDICAL UNIVERSITY   (Belarus)

^c The Republican Research and Practical Center of Pediatric Oncology and Hematology   (Belarus)

Author keywords

Liver cirrhosis; Mesenchymal bone marrow stem cells; Transplantation therapy

Indexed keywords

EID: 84948990584     PISSN: 22250719     EISSN: 23108819     Source Type: Journal    
DOI: 10.14218/JCTH.2014.00027     Document Type: Article

References (28)

1. Zatonski WA, Sulkowska U, Manczuk M, Rehm J, Boffetta P, Lowenfels AB, et al. Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe. Eur Addict Res 2010;16:193–201. doi: 10.1159/000317248.
2. Forbes SJ, Newsome PN. New horizons for stem cell therapy in liver disease. J Hepatol 2012;56:496–499. doi: 10.1016/j.jhep.2011.06.022.
3. Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010;7:425–436. doi: 10.1038/nrgastro.2010.97.
4. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007;10:459–466.
5. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008;8:726–736. doi: 10.1038/nri2395.
6. Zhang L, Theise N, Chua M, Reid LM. The stem cell niche of human livers: symmetry between development and regeneration. Hepatol 2008;48:1598– 1607. doi: 10.1002/hep.22516.
7. Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompen-sated liver cirrhosis patients. J Gastroenterol Hepatol 2012;27(Suppl 2): 112–120. doi: 10.1111/j.1440-1746.2011.07024.x.
8. Isaikina Ya I, Aleinikova O.V. Sposob ekspansii mezenkhimalnykh stvolovykh kletok (The way of expansion of mesenchymal stem cells). Afitsiyny biul. / Nats. tsentr intellectual. ulasnastsi 2009;1:93.
9. Millonig GA. Advantages of a phosphate buffer for osmiumtetroxide solutions in fixation. J Appl Physics 1961;32:1637–1643.
10. Watson ML. Staining of tissue sections for electron microscopy with heavy metals. J Biophys Biochem Cyt 1958;4:475–478. doi: 10.1083/jcb.4.4.475.
11. Reynolds ES. The use of lead citrate at high pH as an electron opaque stain in electron microscopy. J Cell Biol 1963;17:208–212. doi: 10.1083/jcb.17.1.208.
12. Vladimirskaya YeB. Mezenkhimalniye stvoloviye kletki (MSK) v kletochnoy terapii (Mesenchymal stem cells (MSC) in cellular therapy). Onkogematol 2007;1:4–16.
13. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103:697–705. doi: 10.1172/JCI5298.
14. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750–1757. doi: 10.1056/NEJM200106073442303.
15. Talens-Visconti R, Bonora A, Jover R, Mirabet V, Carbonell F, Castell JV, et al. Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J Gastroenterol 2006;12:5834–5845. doi: 10.3748/wjg.v12.i36.5834.
16. Luk JM, Wang PP, Lee CK, Wang JH, Fan ST. Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. J Immunol Methods 2005;305:39–47. doi: 10.1016/j.jim.2005.07.006.
17. Seo MJ, Suh SY, Bae YC, Jung JS. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 2005;328:258–264. doi: 10.1016/j.bbrc.2004.12.158.
18. Abdel Aziz MTA, Atta HM, Mahfouz S, Fouad HH, Roshdy NK, Ahmed HH, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 2007;40:893–899. doi: 10.1016/j.clinbiochem.2007.04.017.
19. Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC. Systemic infusion of FLK1+ mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplant 2004;78:83–88. doi: 10.1097/01.TP.0000128326.95294.14.
20. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125–172. doi: 10.1152/physrev. 00013.2007.
21. Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F, et al. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun 2007;363:247–252. doi: 10.1016/j.bbrc.2007.05.150.
22. Zhao DC, Lei JX, Chen R, Yu WH, Zhang XM, Li SN, et al. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rat. World J Gastroentrol 2005;11:3431–3440.
23. Carvalho AB, Quintannilha LF, Dias JV, Paredes BD, Mannheimer EG, Carvalho FG, et al. Bone marrow multipotent mesenchymal stem cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells 2008;26:1307–1314. doi: 10.1634/stemcells.2007-0941.
24. Di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, Novo E, et al. Human mesenchymal stem cells as a two-edged sword in hepatic regen-erative medicine: engraftment and hepatocyte differentiation versus profi-brogenic potential. Gut 2008;57:223–231. doi: 10.1136/gut.2006.111617.
25. Russo FP, Alison MR, Bigger BW, Amofah E, Florou A, Amin F, et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterol 2006;130: 1807–1821. doi: 10.1053/j.gastro.2006.01.036.
26. Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009;21:1199–1205. doi: 10.1097/MEG.0b013e32832a1f6c.
27. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006;24:2292–2298. doi: 10.1634/stemcells.2005-0542.
28. Lukashyk SP, Tsyrkunov VM, Andreev VP, Kravchuk RI, Abakarova VA. Patogeneticheskaya rol populiatsiyi zvezdchatykh kletok Ito i kletochnykh koopertsiy v formirovanii fibroza pri khronicheskom gepatite C (Pathogenetic role of population of Ito stellate cells and cellular cooperation in formation of fibrosis in chronic C hepatitis). Infektsionniye bolezni 2010;8:7–12.